Study Reveals Use of Active Ingredient in Topamax During Pregnancy Increases Risk of Oral Birth Defe

A recent study performed and published by researchers from Harvard University, MassGeneral Hospital for Children and Loyola University in Chicago, entitled Comparative Safety of Topiramate During Pregnancy, revealed in its conclusion that women who ingest topiramate, the active ingredient in a medication known as Topamax, increased the risk that their children would be born with major oral birth defects. The Consumer Justice Foundation is continuing with its effort to bring this critical information to the public along with providing informational resources such as http://www.topamaxbirthin
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories